TerrAscend (TSNDF) EBITDA (2021 - 2026)
TerrAscend's (TSNDF) quarterly EBITDA came in at $11.5 million in Q1 2026, down 5.9% year-on-year from $12.2 million in Q1 2025, and up 50.31% on a QoQ basis from $7.7 million in Q4 2025.
TerrAscend (TSNDF) EBITDA (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of EBITDA data on file, last reported at $11.5 million in Q1 2026.
- On a quarterly basis, EBITDA fell 5.9% year-over-year to $11.5 million in Q1 2026; TTM through Mar 2026 was $41.3 million, a 1.21% decrease from a year earlier, with the FY2025 full-year figure at $42.0 million, up 7.96% from the prior year.
- EBITDA for Q1 2026 stood at $11.5 million, up from $7.7 million in the prior quarter.
- Over the last five years, EBITDA for TSNDF reached as high as $17.7 million in Q3 2023 and fell as low as -$330.1 million in Q3 2022.
- Historically, EBITDA has averaged -$12.8 million across 5 years, with a median of $7.7 million in 2025.
- Across the five-year window, EBITDA plunged 18550.56% in 2022 and jumped 204.12% in 2024, its largest moves.
- Year by year, EBITDA stood at $13.7 million in 2022, then sank by 65.69% to $4.7 million in 2023, then jumped by 147.7% to $11.7 million in 2024, then sank by 34.31% to $7.7 million in 2025, then surged by 50.31% to $11.5 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were $11.5 million in Q1 2026, $7.7 million in Q4 2025, and $11.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 11.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.52 Mn |
| Dec 31, 2025 | 7.67 Mn |
| Sep 30, 2025 | 11.14 Mn |
| Jun 30, 2025 | 10.97 Mn |
| Mar 31, 2025 | 12.24 Mn |
| Dec 31, 2024 | 11.67 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 10.64 Mn |
| Mar 31, 2024 | 6.07 Mn |
| Dec 31, 2023 | 4.71 Mn |
| Sep 30, 2023 | 17.72 Mn |
| Jun 30, 2023 | 3.50 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 13.73 Mn |
| Sep 30, 2022 | -330.12 Mn |
| Jun 30, 2022 | -11.56 Mn |
| Mar 31, 2022 | -7.98 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Sep 30, 2021 | -1.77 Mn |
| Jun 30, 2021 | 12.24 Mn |